APHRODIL

This brand name is authorized in Nigeria.

Active ingredients

The drug APHRODIL contains one active pharmaceutical ingredient (API):

1	Clomipramine UNII 2LXW0L6GWJ - CLOMIPRAMINE HYDROCHLORIDE
	The therapeutic activity of clomipramine is believed to be based on its ability to inhibit the neuronal re-uptake of noradrenaline (NA) and serotonin (5-HT) released in the synaptic cleft, with inhibition of 5-HT reuptake being the more important of these activities.
	Read more about Clomipramine

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100365	Tablet	Aphrodil Tablets (no NRN) TAB 25 mg 3 x 10's (in blisters)	Film Coated Tablet White colored, circular, deep, biconvex, film coated tablet 11 NF-PP-299922 APHRODIL TABLETS 25MG CLOMIPRAMINE HYDROCHLORIDE TABLETS 25MG Clomipramine HCl 25mg, Starch. Microcrystalline Cellulose, Povidone, Magnesium Stearate, Croscarmellose Sodium, Colloidal anhydrous silica, Propyl hydroxybenzoate, Methyl hydroxybenzoate, Purified talc Drugs NERVOUS SYSTEM Imported Products 3X10 POM 2 12/22/2022 TEKA PHARMACEUTICALCOMPANY LTD, ,ZUNGERU ROAD, NOMANSLAND KANO KANO 7066430624 tekapharmaceuticalco@outlook.com HAB PHARMACEUTICALS AND RESEARCH LIMITED, PLOT N0. 10, PHARMACITY, SIDCUI, SELAQUI, DEHRADUN, UTTARAKHAND-248 011, INDIA., India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AA04	Clomipramine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AA Non-selective monoamine reuptake inhibitors
Discover more medicines within N06AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100365